Order Restylane® Defyne w/ Lidocaine for Clinics

Restylane® Defyne w/ Lidocaine is a hyaluronic acid injectable gel supplied in a 1 mL prefilled syringe for professional facial soft-tissue augmentation. Licensed clinics, med spas, and healthcare professionals can order Restylane® Defyne with Lidocaine for treatment-room use when it fits their protocols for dynamic facial areas. Each unit is intended for sterile, single-use administration and includes integrated lidocaine to support patient comfort during injection.

This preparation is commonly selected by trained injectors for deeper facial folds, marionette-line correction, and chin projection planning. Its gel profile is designed to provide support while accommodating normal facial movement, which makes it relevant for practices that treat animated lower-face regions. Clinic documentation, lot tracking, sterile handling, and injector training should guide purchasing and procedure-room use.

Clinic Price, Unit Selection, and Ordering

Restylane® Defyne with Lidocaine price visibility is account-based for professional purchasers. Sign in to view current clinic pricing, request a quote, and align the 1 mL syringe quantity with scheduled cases or monthly inventory planning. The exact cost can vary by account tier, volume, and ordering arrangement, so inventory teams should use the current cart or quote workflow rather than relying on historical invoices.

The labeled unit is a Restylane® Defyne 1 mL syringe with lidocaine. The preparation is listed with hyaluronic acid 20 mg/mL and lidocaine 3 mg/mL, and the carton includes two sterile 27G 1/2 inch needles, a package insert, and patient record labels. These components support standard treatment-room preparation, traceability, and post-procedure charting within clinic protocols.

Professional accounts may plan a Restylane® Defyne with Lidocaine bulk order when recurring demand is predictable. Bulk planning should still account for lot rotation, expected procedure volume, practitioner preference, and the practice’s storage capacity. Orders are supported through US distribution and reliable US logistics, with temperature-controlled handling when required and tracked US delivery.

What the Injectable Gel Is and How It Works

Restylane® Defyne with Lidocaine is a crosslinked hyaluronic acid dermal filler. Hyaluronic acid is a naturally occurring water-binding molecule, and crosslinking helps the gel maintain structure after placement in soft tissue. The lidocaine component is incorporated into the gel to reduce injection discomfort during administration, although clinics may use additional comfort measures when appropriate under their own protocols.

The Defyne formulation is designed for resilient correction in areas that move with facial expression. In practical terms, injectors may consider it when a case needs support for deeper folds or contouring while preserving a natural look during animation. Product selection should reflect the patient’s anatomy, tissue quality, treatment history, and the injector’s technique.

Clinics often stock this product within a broader HA filler portfolio so practitioners can match rheology to the treatment area. For foundational category planning, the Restylane dermal filler treatment guide provides context on how products in the Restylane family may be positioned across aesthetic workflows. Broader brand browsing is available through the Restylane professional product range.

Professional Applications and Treatment-Room Fit

Restylane® Defyne injectable gel with Lidocaine may be used by trained professionals for softening pronounced nasolabial folds, addressing marionette lines, and supporting chin definition when those uses align with the applicable label and clinic standards. It is not a self-administered product. Administration requires appropriate clinical training, facial anatomy knowledge, aseptic technique, and readiness to manage filler-related adverse events.

For consultation-driven workflows, Defyne can fit staged correction plans. A practitioner may use conservative placement, reassess symmetry and tissue response, and schedule follow-up according to clinic protocol. The 1 mL syringe format can support targeted correction while allowing the clinic to document lot number, injection site, volume used, technique, and follow-up instructions.

In practices offering multiple Restylane products, Defyne is often evaluated alongside formulations with different support or flexibility characteristics. For moderate dynamic lines, Restylane® Refyne with Lidocaine may be considered as a related expression-focused option. When midface lift or deeper structural support is the primary objective, Restylane® Lyft with Lidocaine may be part of the clinic’s comparison set.

Key Features for Inventory and Procedure Planning

• Crosslinked hyaluronic acid gel designed for professional soft-tissue augmentation.
• Integrated lidocaine 3 mg/mL to support comfort during injection.
• Hyaluronic acid concentration listed as 20 mg/mL.
• Restylane® Defyne Lidocaine 1ml syringe format for targeted procedures.
• Sterile, single-use device intended for trained healthcare professionals.
• Two sterile 27G 1/2 inch needles included with the unit.
• Patient record labels and package insert support clinical documentation.
• Cohesive gel behavior supports controlled extrusion through recommended technique.
• Product SKU: 87773 for internal purchasing and inventory reference.

Quick tip: Match planned monthly case volume to lot rotation so product is used within clinic inventory controls.

Composition, Packaging, and Documentation

Each unit includes one 1 mL prefilled syringe, two sterile needles, a package insert, and patient record labels. The typical labeled composition is hyaluronic acid 20 mg/mL with lidocaine 3 mg/mL in a sterile gel preparation. Full excipient details, indications, contraindications, warnings, and instructions belong in the manufacturer’s package insert and should be reviewed by the clinical team before use.

Traceability is important for aesthetic injectable inventory. Clinics should record the product name, lot number, expiration date, treatment area, amount administered, injector, and any relevant follow-up details in the patient record. The included labels can help standardize this workflow and reduce transcription errors during busy procedure sessions.

Before bringing the product into the treatment room, staff should inspect the carton and syringe integrity, verify the product against the scheduled procedure, and confirm that the practitioner has selected the appropriate filler for the mapped area. Units are single use only and should not be saved or reused after a procedure. Ancillary device planning can include cannulas, antiseptic supplies, sharps disposal, and other procedure-room items permitted by clinic policy.

Storage, Handling, and Clinic Workflow

Store Restylane® Defyne w/ Lidocaine according to the manufacturer’s instructions on the carton and package insert. Inventory staff should keep cartons protected from conditions outside labeled storage parameters and use first-in, first-out rotation. Product should remain in its original packaging until clinic workflow requires removal for a scheduled procedure.

Sterile handling matters because dermal fillers are implanted medical devices. Staff should maintain aseptic preparation, confirm needle sterility, and avoid using any unit with damaged packaging, compromised seals, particulate concerns, or unclear labeling. The syringe and supplied needles are intended for single-patient, single-procedure use.

Operationally, many clinics create filler trays or checklists that include patient consent documentation, pre-procedure photography requirements, skin antisepsis supplies, emergency response materials, and post-procedure instructions. If your practice manages several fillers, the role of lidocaine in dermal filler procedures may help teams standardize comfort-related discussions without confusing lidocaine content with product selection.

Safety, Contraindications, and Adverse Effects

Restylane® Defyne w/ Lidocaine should be used only by appropriately trained professionals who understand injection anatomy and filler risk management. Common local reactions can include injection-site pain, itching, swelling, bruising, tenderness, redness, and firmness. These effects are usually procedure-related, but clinics should assess severity, duration, and whether symptoms suggest infection, vascular compromise, hypersensitivity, or another complication.

Contraindications listed in current content include severe allergies or a history of anaphylaxis and known hypersensitivity to Gram-positive bacterial proteins. Because the gel contains lidocaine, clinicians should also consider patient history relevant to local anesthetics and use the manufacturer’s current instructions for full contraindication and warning language. Do not inject into areas with active infection or inflammation unless the applicable labeling and clinical judgment support treatment after resolution.

Serious filler complications are uncommon but require prompt recognition. Vascular occlusion, skin changes, visual symptoms, severe pain, neurologic symptoms, or unexpected tissue compromise should be treated as urgent clinical concerns. Clinics should maintain protocols for complication management, staff escalation, patient follow-up, and adverse event reporting when required.

Drug or procedure interactions may arise from anticoagulant use, antiplatelet therapy, recent dental work, skin procedures, or inflammatory skin conditions. These factors do not automatically determine product choice, but they should be addressed during professional assessment and consent. The product should be used according to the package insert, professional training, and the clinic’s medical director policies.

How It Compares Within a Filler Portfolio

Defyne is commonly positioned as an HA filler for areas needing both support and flexibility. In contrast, some fillers are chosen primarily for fine superficial lines, lip shaping, volumization, or more structural contour. The most useful comparison is not simply brand versus brand; it is gel behavior, treatment depth, anatomical target, patient presentation, and injector technique.

Within the Restylane family, clinics may stock several formulations to avoid forcing one gel into every indication. Restylane® 1 mL with Lidocaine may be used as a related HA filler option when the practitioner’s protocol calls for that formulation. For lip-focused workflows, Restylane® Kysse with Lidocaine may be more relevant to practices emphasizing lip texture, shape, and movement.

Some clinics also compare Restylane products with other HA filler families for procurement planning. The Restylane and Juvederm comparison can support internal discussions about product families, while final selection should remain with the treating professional and the clinic’s approved formulary. When the practice needs cheek or volume planning, Restylane® Volyme with Lidocaine may be evaluated as a related option.

Duration, Patient Expectations, and Follow-Up Planning

Many clinicians and patients ask how long Restylane® Defyne results last. Duration can vary by treatment area, injection technique, amount used, patient metabolism, tissue movement, and follow-up plan. Official patient-facing materials commonly discuss duration in general terms, but clinics should avoid promising a fixed result window for every case.

For operational planning, duration expectations influence recall scheduling and inventory forecasting. Practices may schedule follow-up visits to assess contour, symmetry, and patient satisfaction after swelling has settled. Touch-up decisions should be based on clinical evaluation rather than automatic repeat injection.

Post-procedure instructions should reflect clinic policy and manufacturer guidance. Typical counseling may address expected swelling or bruising, when to contact the clinic, and activity precautions after treatment. If a patient reports severe pain, blanching, visual changes, progressive swelling, or signs of infection, the clinic should respond promptly according to its escalation pathway.

Wholesale Purchasing and Account Support

Med Wholesale Supplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels. Account verification may be required before professional inventory is released. This helps ensure that aesthetic injectables are purchased for appropriate clinical environments and managed by qualified teams.

When preparing an order, confirm the product name, unit size, case quantity, and any internal SKU requirements. Restylane® Defyne with Lidocaine wholesale pricing can be reviewed through account access or a quote request. Practices with multiple injectors may benefit from standardizing purchasing notes so staff can distinguish Defyne from Refyne, Lyft, Kysse, and other HA fillers with similar packaging language.

Procurement teams should coordinate order timing with scheduled treatment days, staff availability, and receiving procedures. On receipt, inspect packaging, confirm lot and date details, and place units into the appropriate storage area. Document any receiving concerns before releasing product to clinical staff.

Authoritative Sources

• Manufacturer information for Restylane® Defyne
• Restylane® Defyne instructions for use
• FDA-accessible directions for use

This content is for informational purposes only and is not a substitute for professional medical advice.